Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Musi

Showing results (101-110 of 145) with videos related to

Pageof 15
Sort By:
Hepatology (Baltimore, Md.)|May 2, 2023
Targeting hepatic serine-arginine protein kinase 2 ameliorates alcohol-associated liver disease by alternative splicing control of lipogenesisGuannan Li, Hanqing Chen, Feng Shen, et al.
The Journal of Clinical Endocrinology and Metabolism|March 17, 2016
Diabetes Incidence and Glucose Tolerance after Termination of Pioglitazone Therapy: Results from ACT NOWDevjit Tripathy, Dawn C Schwenke, MaryAnn Banerji, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 28, 2023
microRNA-449a reduces growth hormone-stimulated senescent cell burden through PI3K-mTOR signalingSarah Noureddine, Jia Nie, Augusto Schneider, et al.
Circulation|November 9, 2005
Increased alpha2 subunit-associated AMPK activity and PRKAG2 cardiomyopathyFerhaan Ahmad, Michael Arad, Nicolas Musi, et al.
Aging Cell|November 4, 2020
Rapamycin-mediated mouse lifespan extension: Late-life dosage regimes with sex-specific effectsRandy Strong, Richard A Miller, Molly Bogue, et al.
Diabetes Care|April 8, 2014
Baseline adiponectin levels do not influence the response to pioglitazone in ACT NOWDevjit Tripathy, Stephen C Clement, Dawn C Schwenke, et al.
Diabetes|July 19, 2012
Fat-specific DsbA-L overexpression promotes adiponectin multimerization and protects mice from diet-induced obesity and insulin resistanceMeilian Liu, Ruihua Xiang, Sarah Ann Wilk, et al.
Diabetes|July 19, 2013
Prevention of diabetes with pioglitazone in ACT NOW: physiologic correlatesRalph A Defronzo, Devjit Tripathy, Dawn C Schwenke, et al.
Diabetes Care|September 25, 2013
Prediction of diabetes based on baseline metabolic characteristics in individuals at high riskRalph A Defronzo, Devjit Tripathy, Dawn C Schwenke, et al.
Aging Cell|May 31, 2017
Sustained NFκB inhibition improves insulin sensitivity but is detrimental to muscle healthNing Zhang, Joseph M Valentine, You Zhou, et al.
Pageof 15

Showing results (101-110 of 145) with videos related to

Sort By:
Pageof 15
Hepatology (Baltimore, Md.)|May 2, 2023
Targeting hepatic serine-arginine protein kinase 2 ameliorates alcohol-associated liver disease by alternative splicing control of lipogenesisGuannan Li, Hanqing Chen, Feng Shen, et al.
The Journal of Clinical Endocrinology and Metabolism|March 17, 2016
Diabetes Incidence and Glucose Tolerance after Termination of Pioglitazone Therapy: Results from ACT NOWDevjit Tripathy, Dawn C Schwenke, MaryAnn Banerji, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 28, 2023
microRNA-449a reduces growth hormone-stimulated senescent cell burden through PI3K-mTOR signalingSarah Noureddine, Jia Nie, Augusto Schneider, et al.
Circulation|November 9, 2005
Increased alpha2 subunit-associated AMPK activity and PRKAG2 cardiomyopathyFerhaan Ahmad, Michael Arad, Nicolas Musi, et al.
Aging Cell|November 4, 2020
Rapamycin-mediated mouse lifespan extension: Late-life dosage regimes with sex-specific effectsRandy Strong, Richard A Miller, Molly Bogue, et al.
Diabetes Care|April 8, 2014
Baseline adiponectin levels do not influence the response to pioglitazone in ACT NOWDevjit Tripathy, Stephen C Clement, Dawn C Schwenke, et al.
Diabetes|July 19, 2012
Fat-specific DsbA-L overexpression promotes adiponectin multimerization and protects mice from diet-induced obesity and insulin resistanceMeilian Liu, Ruihua Xiang, Sarah Ann Wilk, et al.
Diabetes|July 19, 2013
Prevention of diabetes with pioglitazone in ACT NOW: physiologic correlatesRalph A Defronzo, Devjit Tripathy, Dawn C Schwenke, et al.
Diabetes Care|September 25, 2013
Prediction of diabetes based on baseline metabolic characteristics in individuals at high riskRalph A Defronzo, Devjit Tripathy, Dawn C Schwenke, et al.
Aging Cell|May 31, 2017
Sustained NFκB inhibition improves insulin sensitivity but is detrimental to muscle healthNing Zhang, Joseph M Valentine, You Zhou, et al.
Pageof 15